Medical research and development laboratories or services (except biotechnology research and development) · New Jersey

Abon Pharmaceuticals

Northvale, NJ · ~25 workers · 5 years of OSHA Injury Tracking Application data.

F
Failing Safety Record
2.4
Avg TCR
0.5
Industry avg
0
Fatalities

The verdict

Abon Pharmaceuticals runs at 476% of its industry's injury rate - far more dangerous than the typical Medical research and development laboratories or services (except biotechnology research and development) workplace, earning a grade F.

F
Failing Safety Record
2.4
avg TCR · per 100 workers
0.5
industry benchmark (BLS)
3
recordable injuries tracked

Grade compares Abon Pharmaceuticals's OSHA Total Case Rate of 2.4 to the Medical research and development laboratories or services (except biotechnology research and development) BLS benchmark of 0.5 (476% of benchmark) across 5 years of Form 300A filings (2016–2024). <a href="/methodology">See methodology</a> for reporting-limitation caveats.

Injury rate over time

Abon Pharmaceuticals's yearly Total Case Rate, against the 0.5 industry benchmark.

-1012345 20162017201820192021 00.5 Industry benchmarkAbon Pharmaceuticals TCR
Total Case Rate (recordable injuries per 100 full-time workers), OSHA ITA Form 300A. Industry benchmark: BLS IIF, NAICS 541712.

Where Abon Pharmaceuticals falls in its industry

474 Medical research and developme establishments

Safer than 8% of graded establishments in this industry, whose median TCR is 0.3.

More dangerous than peersSafer than peers

Narrower to New Jersey alone (the establishments it most directly competes with for workers and contracts): ranked #18 safest of 20 Medical research and developme employers in New Jersey.

Trend analysis for Abon Pharmaceuticals

Between 2016 and 2021, Abon Pharmaceuticals's Total Case Rate held roughly steady from 0.0 to 0.0 recordable injuries per 100 full-time workers, a 0% change across 5 years of OSHA reporting.

The safest year on record was 2016, at a TCR of 0.0, while 2019 saw the highest rate, at 4.4, a spread of 4.4 points between the best and worst reporting years. That's a wide swing relative to the establishment's overall rate, worth checking the year-by-year table below for whether a single severe year is driving the average, rather than a sustained trend.

Summed across those 5 reporting years, Abon Pharmaceuticals recorded 3 total injuries and illnesses, with no fatalities reported in any of those years. Readers comparing establishments should weigh the 5-year trend above alongside establishment size, since a larger workforce naturally accumulates more raw incidents even at a lower per-100-worker rate.

Verify This Employer with OSHA

The 3 injuries shown on this page for Abon Pharmaceuticals are sourced from its own 5 years of mandatory OSHA Form 300A summaries. Cross-check the underlying establishment record directly against the federal source, name, NAICS classification, recordable case totals, and inspection history are all searchable on OSHA's Establishment-Specific Injury and Illness Data system.

Verify on OSHA Establishment Search

Source: U.S. Department of Labor, OSHA Establishment-Specific Injury and Illness Data. NAICS 541712 - Medical research and development laboratories or services (except biotechnology research and development).

DART Rate, Transparent Calculation (2021)

What is the DART rate formula?

DART (Days Away, Restricted, or Transferred) is computed by OSHA as incidents × 200,000 ÷ hours worked. The 200,000-hour denominator equals roughly 100 full-time workers, which lets establishments of very different sizes be compared directly.

0 DART incidents × 200,000 ÷ 47,840 hours worked = 0.00 DART

Methodology: 29 CFR 1904, OSHA Form 300A recordkeeping

Cross-Validating Context, Establishment vs Industry vs State

Benchmark TCR Source
Abon Pharmaceuticals (this establishment) 2.38 OSHA ITA Form 300A, 5-year avg
Electronic research and development laboratories or services industry avg 0.50 BLS IIF, NAICS 541712
New Jersey state avg (all industries) 4.90 OSHA ITA, state-level rollup

Industry benchmarks: Bureau of Labor Statistics, Injuries, Illnesses, and Fatalities (IIF) program

Reportable Incident Timeline

Year-by-year reportable incidents (recordable injuries + illnesses + fatalities) submitted by Abon Pharmaceuticals to OSHA's Injury Tracking Application. Each row anchors to OSHA's inspection records search where you can pull the underlying inspection case numbers and citations for that establishment-year.

Source: OSHA Inspection Information System (IMIS) - inspection case-number records

Year-by-Year Safety Data

Year TCR DART Injuries Illnesses Fatalities
2021 0.0 0.0 0 0 0
2019 4.4 4.4 1 0 0
2018 3.9 0.0 1 0 0
2017 3.7 0.0 1 0 0
2016 0.0 0.0 0 0 0

What this grade means for you

Use this grade as a relative read on Abon Pharmaceuticals's reported OSHA injury record versus its Medical research and development laboratories or services (except biotechnology research and development) peers, not a verdict on whether any single site is safe today.

  • At 476% of the Medical research and development laboratories or services (except biotechnology research and development) benchmark, Abon Pharmaceuticals reports more injuries than typical peers, ask specifically how the employer is reducing them. Know your rights
  • Judge this record against the wider Medical research and development laboratories or services (except biotechnology research and development) sector, where injury rates vary widely, before comparing it in isolation. See the industry
  • Grades reflect 2016–2024 filings; check the latest establishment record straight from OSHA, or look up a different employer. Look up another

Safety grades reflect employers' self-reported OSHA Form 300A filings from 2016 to 2024 and can lag current conditions. A grade is not a guarantee that any specific workplace is safe or unsafe today. See our methodology and disclaimer.

Frequently Asked Questions

What is Abon Pharmaceuticals's safety grade?
Abon Pharmaceuticals has a safety grade of F (Failing Safety Record). This grade is based on their average Total Case Rate (TCR) of 2.4 compared to the BLS industry benchmark of 0.5 for Medical research and development laboratories or services (except biotechnology research and development).
How many injuries has Abon Pharmaceuticals reported?
Abon Pharmaceuticals has reported 3 total injuries and 0 fatalities across 5 years of OSHA data (2021, 2019, 2018, 2017, 2016). This data comes from mandatory OSHA Injury Tracking Application (ITA) reports.

Similar Employers

Matched by safety record across the industry, by workforce size within New Jersey, and by nearby establishments in Northvale - a different peer set than the category browse links below.

Similar TCR (~2.4)

Similar size (~25 workers)

Nearby in Northvale

Data Source: OSHA Injury Tracking Application (ITA), mandatory establishment-level injury/illness reports. Grades compare employer Total Case Rate (TCR) to BLS IIF industry benchmarks. Data covers years reported by this establishment: 2021, 2019, 2018, 2017, 2016. This is publicly available government data - not a legal determination of workplace conditions.

Read our methodology - how this data is sourced, computed, and verified.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainSafetyScore Editorial

Every figure and grade on PlainSafetyScore is computed directly from OSHA's published Injury Tracking Application data and BLS industry benchmarks, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these safety grades, or report a data error. Data current as of 2016-2024 OSHA ITA release.